# Characterization of Two Novel Mutations in the Apob Gene

> **NCT03963037** · — · UNKNOWN · sponsor: **Medical University Innsbruck** · enrollment: 16 (estimated)

## Conditions studied

- Familial Hypobetalipoproteinaemia - Heterozygous Form
- Low-LDL-syndrome

## Interventions

- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT03963037
- **Lead sponsor:** Medical University Innsbruck
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-24
- **Primary completion:** 2021-01
- **Final completion:** 2022-01
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963037

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963037, "Characterization of Two Novel Mutations in the Apob Gene". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03963037. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*